The patient journey in Chronic Obstructive Pulmonary Disease (COPD): a human factors qualitative international study to understand the needs of people living with COPD.

Publication Year: 2023

DOI:
10.1186/s12890-023-02796-8

PMCID:
PMC10720133

PMID:
38093262

Journal Information

Full Title: BMC Pulm Med

Abbreviation: BMC Pulm Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe DL 20 marzo 2008 specifies that interviews to the patients without any clinical intervention (as the present study) are not considered observational studies and, thus, don't need to be submitted to the revision and approval of an Ethical committee.All patients provided their informed consent to participate in this study. The informed consent included statements that required participants to agree to maintain confidentiality regarding the information shared during the study session, as well as described the conditions for the collection, use, processing, retention, and transfer of their personal data (including personally identifiable information and personal health information). Consent for publicationNot applicable. Competing interestsNS declares no competing interests.AW declares no competing interests.CW is a full-time employee of Rebus Medical.EN, MS, and ML are full-time employees of Chiesi Farmaceutici. Competing interests NS declares no competing interests. AW declares no competing interests. CW is a full-time employee of Rebus Medical. EN, MS, and ML are full-time employees of Chiesi Farmaceutici."

Evidence found in paper:

"Funding All the activities were funded by Chiesi Farmaceutici S.p.A. (Parma, Italy)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025